fda warning letters bpc-157 2023 2024 2025 issued 25 to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA to weigh easing limits
FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News US FDA CDRH Warning Letters: A Review of 2025 NBC News The claims surrounding peptides are sweeping: They're promoted as treatments for everything from faster healing to younger looking skin, Instagram An FDA Committee Just Voted in Favor of PeptidesDespite the Agency's Opposition Modernized Food Manufacturing Enforcement: Trends in FDA Warning Letters Food and Drug Law Institute (FDLI)
Pay in 4 interest-free payments of $7.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7



